Here is the synopsis of our sample research paper on Stem Cell Therapy. Have the paper e-mailed to you 24/7/365.
Essay / Research Paper Abstract
A 2 page paper discussing the stem cell aspect of chemotherapy. Stem cells are the progenitor cells of all types of blood cells, including the white blood cells that combat infection and invasion, and red blood cells that supply nourishment to all the tissues of the body. They primarily reside in the bone marrow, but some also can be found circulating in the blood. Cancer chemotherapy depresses bone marrow activity so that fewer blood cells are produced. Stem cell therapy involves harvesting bone marrow prior to chemotherapy treatment, then reintroducing it following treatment so that blood cell production can occur at optimum rates. Bibliography lists 2 sources.
Page Count:
2 pages (~225 words per page)
File: CC6_KSstem.doc
Buy This Term Paper »
Unformatted sample text from the term paper:
chemotherapy. Reportedly not as distasteful now as in the past, the treatments still can severely depress bone marrow activity. Because bone marrow is the site of all types
of blood cell production, depressed activity that remains depressed also slows treatment progress. Stem cells are the progenitor cells of all types of
blood cells, including the white blood cells that combat infection and invasion, and red blood cells that supply nourishment to all the tissues of the body. They primarily reside
in the bone marrow, but some also can be found circulating in the blood (Rovito and Sprandio, 1997). Stem cell therapy involves harvesting these cells prior to cancer chemotherapy
and then reintroducing them after the completion of the chemotherapy while bone marrow activity is still depressed. The therapy is a multi-step process.
Patients frequently are subjected to a pre-treatment round of chemotherapy designed to enhance the production of these stem cells, which are then harvested by removing bone marrow. The
marrow is preserved for the course of the cancer chemotherapy that follows and can last for several weeks, after which the stem cell-rich marrow is reintroduced to the patient.
The therapy allows blood cell production to progress at the highest possible rate, even though bone marrow activity is depressed and the patient otherwise would not be producing new blood
cells at either the same rate or in the same quantity as are possible through stem cell therapy. A variation of the same
theme can be found in the use of umbilical cord blood for the same types of purposes. Cord blood is even more rich in stem cells than is bone
...